Drug
Procrit
Procrit: highest development phase Phase 2, developed by Johnson & Johnson. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Johnson & Johnson
Trials
| Drug | Phase | Indication |
|---|---|---|
| PROCRIT NCT00210626 | Phase 2 | Anemia |
Latest
No recent events.
Follow Procrit on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.